Annals of Oncology 10:S73-S76, 1999
© 1999 European Society for Medical Oncology
Reviews |
The role of surgery in integrated therapies for non-small-cell lung cancer
1 Divisions of Thoracic Surgery
2 Divisions of Medical Oncology, University of Padua Padua, Italy
Correspondence to: L. Bortolotti, MD Divisione Chirurgia Toracica Policlinico Universitario via Giustiniani 2 35128 Padova Italy E-mail: chirtor@uxl.unipd.it
Surgery represents the best treatment for early-stage non-small-cell lung cancer (NSCLC). In selected cases, even locally-advanced cancers may be suitable for surgical treatment. The combination of chemotherapy (with or without radiotherapy) and surgery has proved potentially useful in improving survival, but pre-operative treatment may represent a risk factor for the onset of post-operative complications. Studies performed to date indicate the need for further multidisciplinary research with a view to identifying more advantageous treatment modalities, particularly for locally-advanced NSCLC.
combined modalities, non-small-lung cancer, surgery